Investor Relations


We are focused on developing and commercializing drugs that treat rare diseases.

NASDAQ: INSM
$ 12.37 +0.22 (1.77%)
Day High: 12.37
Day Low:  11.81
Volume:    135,724
3:04 PM ET
May 2, 2016

Delayed ~20 min., by eSignal.

Investor Materials

View the latest Insmed Investor Presentation here.

LEARN MORE

Key Clinical Publications

Insmed actively publishes and presents clinical data for its product candidates.

LEARN MORE

Email Alerts

Want to stay up to date on our news, events, and filings?
Set up your email alerts.

SIGN UP

Investor & Media Contacts

Insmed Investor Relations

Susan Mesco | 908.947.4326

EMAIL